• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在大环内酯类耐药性增加期间收集的A组链球菌中的耐药决定因素和克隆多样性。

Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance.

作者信息

Cresti Stefania, Lattanzi Maria, Zanchi Alessandra, Montagnani Francesca, Pollini Simona, Cellesi Carla, Rossolini Gian Maria

机构信息

Clinica delle Malattie Infettive, Sezione di Microbiologia, Dipartimento di Biologia Molecolare, Università degli Studi di Siena, I-53100 Siena, Italy.

出版信息

Antimicrob Agents Chemother. 2002 Jun;46(6):1816-22. doi: 10.1128/AAC.46.6.1816-1822.2002.

DOI:10.1128/AAC.46.6.1816-1822.2002
PMID:12019095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC127250/
Abstract

Susceptibility to macrolides and lincosamides was investigated with 299 consecutive nonduplicate Streptococcus pyogenes clinical isolates collected over a 6-year period (1992 to 1997) from an area of central Italy. During this period, macrolide resistance rates steadily increased (from 9% in 1992 to 53% in 1997; P < 0.001). The increase was caused by isolates with a macrolide-lincosamide-streptogramin B resistance phenotype, carrying mostly erm(B) but also erm(TR) genes, that were not detected in the first 2 years and were detected with increasing prevalence (8, 5, 26, and 37%, respectively) during the following 4 years. During the same period, the prevalence of isolates with a macrolide resistance phenotype, carrying mef(A) determinants, did not vary significantly; on average it was 13%, with modest rate fluctuations in different years and no definite trend. Molecular typing revealed a remarkable clonal diversity among susceptible and resistant isolates and a notable heterogeneity of the genetic environment of the resistance genes. The analysis of clonal diversity in relation with resistance phenotypes and genotypes revealed that increased macrolide resistance rates were due to a complex interplay of different mechanisms, with a relevant contribution played by an "epidemic" spread of genetic elements carrying the erm(B) gene among the circulating streptococcal population.

摘要

对1992年至1997年6年间从意大利中部一个地区收集的299株连续非重复化脓性链球菌临床分离株进行了大环内酯类和林可酰胺类药物敏感性研究。在此期间,大环内酯类耐药率稳步上升(从1992年的9%升至1997年的53%;P<0.001)。这种上升是由具有大环内酯-林可酰胺-链阳菌素B耐药表型的分离株引起的,这些分离株大多携带erm(B)基因,但也携带erm(TR)基因,前两年未检测到,在随后4年中检测到的流行率逐渐增加(分别为8%、5%、26%和37%)。在同一时期,携带mef(A)决定簇的具有大环内酯耐药表型的分离株的流行率没有显著变化;平均为13%,不同年份有适度的波动且无明确趋势。分子分型显示敏感和耐药分离株之间存在显著的克隆多样性,耐药基因的遗传环境存在明显的异质性。对与耐药表型和基因型相关的克隆多样性分析表明,大环内酯耐药率的增加是由于不同机制的复杂相互作用,携带erm(B)基因的遗传元件在循环链球菌群体中的“流行”传播起到了相关作用。

相似文献

1
Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance.在大环内酯类耐药性增加期间收集的A组链球菌中的耐药决定因素和克隆多样性。
Antimicrob Agents Chemother. 2002 Jun;46(6):1816-22. doi: 10.1128/AAC.46.6.1816-1822.2002.
2
Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes.化脓性链球菌临床分离株中的大环内酯类耐药基因。
Microb Drug Resist. 2002 Summer;8(2):129-32. doi: 10.1089/107662902760190671.
3
Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).7年期间(2007 - 2013年)儿童分离出的化脓性链球菌大环内酯类耐药性的分子分析
J Antimicrob Chemother. 2016 Aug;71(8):2113-7. doi: 10.1093/jac/dkw116. Epub 2016 Apr 26.
4
Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.韩国β-溶血性链球菌的抗菌药物敏感性模式及大环内酯类耐药基因
Antimicrob Agents Chemother. 2004 Jul;48(7):2716-8. doi: 10.1128/AAC.48.7.2716-2718.2004.
5
Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.宾夕法尼亚州西南部A组链球菌咽部分离株中大环内酯耐药性的再度出现。
Antimicrob Agents Chemother. 2004 Feb;48(2):473-6. doi: 10.1128/AAC.48.2.473-476.2004.
6
Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).在加拿大呼吸道病原体药敏试验(CROSS,1998 - 2004年)的6年期间分离出的肺炎链球菌中的大环内酯类耐药机制。
J Antimicrob Chemother. 2007 Oct;60(4):733-40. doi: 10.1093/jac/dkm273. Epub 2007 Aug 2.
7
Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal.葡萄牙化脓性链球菌对大环内酯类药物耐药性及克隆不稳定性的降低。
Clin Microbiol Infect. 2008 Dec;14(12):1152-9. doi: 10.1111/j.1469-0691.2008.02104.x. Epub 2008 Nov 21.
8
Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.从1999 - 2000年PROTEKT研究中分离出的肺炎链球菌和化脓性链球菌大环内酯类耐药机制的分子特征
J Antimicrob Chemother. 2002 Sep;50 Suppl S1:39-47. doi: 10.1093/jac/dkf806.
9
A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.1996年至2002年期间,波兰分离出的化脓性链球菌对大环内酯类药物的耐药性迅速增加。
J Antimicrob Chemother. 2004 Oct;54(4):828-31. doi: 10.1093/jac/dkh420. Epub 2004 Aug 25.
10
Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.16元环大环内酯类药物及泰利霉素对不同基因型的红霉素敏感及耐药化脓性链球菌和肺炎链球菌的活性。
J Antimicrob Chemother. 2007 Jun;59(6):1171-6. doi: 10.1093/jac/dkm089. Epub 2007 Apr 3.

引用本文的文献

1
Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.长期红霉素治疗对非囊性纤维化支气管扩张患者口咽部微生物组和耐药基因库的影响。
mSphere. 2018 Apr 18;3(2). doi: 10.1128/mSphere.00103-18. Print 2018 Apr 25.
2
Prevalence of M75 Strains Harboring Gene in Patients Affected by Pediatric Obstructive Sleep Apnea Syndrome in Central Italy.意大利中部受小儿阻塞性睡眠呼吸暂停综合征影响的患者中携带该基因的M75菌株的流行情况。
Front Microbiol. 2017 Feb 28;8:294. doi: 10.3389/fmicb.2017.00294. eCollection 2017.
3
Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.在意大利分离出的引起儿童咽炎的化脓性链球菌中,大环内酯类耐药率下降。
Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1797-802. doi: 10.1007/s10096-015-2414-x. Epub 2015 May 30.
4
Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.革兰氏阳性病原体的种群生物学:传播抗生素耐药性的高危克隆。
FEMS Microbiol Rev. 2011 Sep;35(5):872-900. doi: 10.1111/j.1574-6976.2011.00284.x. Epub 2011 Jul 4.
5
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome.短期抗生素治疗对人体咽喉和肠道微生物组有不同的长期影响。
PLoS One. 2010 Mar 24;5(3):e9836. doi: 10.1371/journal.pone.0009836.
6
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region.意大利中部地区化脓性链球菌的红霉素耐药性及大环内酯类药物的使用情况
Infection. 2009 Aug;37(4):353-7. doi: 10.1007/s15010-008-8023-1. Epub 2008 Dec 5.
7
Clindamycin-resistant Streptococcus pneumoniae.耐克林霉素的肺炎链球菌
Emerg Infect Dis. 2007 May;13(5):801-2. doi: 10.3201/eid1305.060699.
8
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.化脓性链球菌中携带erm(B)的遗传元件及其与tet(M)四环素抗性基因的关联。
Antimicrob Agents Chemother. 2007 Apr;51(4):1209-16. doi: 10.1128/AAC.01484-06. Epub 2007 Jan 29.
9
DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci.DNA甲基化酶活性作为链球菌中一类赋予外排介导的大环内酯抗性的噬菌体样元件存在的标志物。
Antimicrob Agents Chemother. 2006 Nov;50(11):3689-94. doi: 10.1128/AAC.00782-06. Epub 2006 Sep 5.
10
Erythromycin-resistant group a streptococcal isolates collected between 2000 and 2005 in Oahu, Hawaii, and their emm types.2000年至2005年期间在夏威夷瓦胡岛收集的耐红霉素A组链球菌分离株及其致病变异型(emm型)
J Clin Microbiol. 2005 May;43(5):2497-9. doi: 10.1128/JCM.43.5.2497-2499.2005.

本文引用的文献

1
Symposium on epidemiological risks of antibiotics: hospital infection.抗生素的流行病学风险研讨会:医院感染
Proc R Soc Med. 1958 Oct;51(10):807-10. doi: 10.1177/003591575805101006.
2
Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci.A组链球菌中红霉素耐药性与进入人呼吸道细胞能力之间的关联。
Lancet. 2001 Jul 7;358(9275):30-3. doi: 10.1016/s0140-6736(00)05253-3.
3
Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae.肺炎链球菌中编码大环内酯外排的染色体插入元件的结构与传播
J Infect Dis. 2001 Jul 1;184(1):56-65. doi: 10.1086/321001. Epub 2001 May 31.
4
The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens.
J Antimicrob Chemother. 2001 Apr;47(4):475-7. doi: 10.1093/jac/47.4.475.
5
Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.智利圣地亚哥化脓性链球菌对大环内酯类抗生素的耐药性及其机制
Antimicrob Agents Chemother. 2001 Jan;45(1):339-41. doi: 10.1128/AAC.45.1.339-341.2001.
6
Erythromycin resistance genes in group A streptococci of different geographical origins. The Macrolide Resistance Study Group.不同地理来源的A组链球菌中的红霉素抗性基因。大环内酯抗性研究小组。
J Antimicrob Chemother. 2000 Nov;46(5):789-92. doi: 10.1093/jac/46.5.789.
7
Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae.肺炎链球菌中携带大环内酯类外排基因mef(A)的遗传元件的特征分析
Antimicrob Agents Chemother. 2000 Sep;44(9):2585-7. doi: 10.1128/AAC.44.9.2585-2587.2000.
8
Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.台湾南部耐红霉素A群链球菌中含多克隆mefA分离株的流行情况。
J Clin Microbiol. 2000 Jul;38(7):2475-9. doi: 10.1128/JCM.38.7.2475-2479.2000.
9
Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.法国儿科患者中化脓性链球菌对大环内酯类药物的耐药性
Antimicrob Agents Chemother. 2000 Jun;44(6):1453-7. doi: 10.1128/AAC.44.6.1453-1457.2000.
10
Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates.在大环内酯类药物敏感性降低率的5年期间,社区获得性肺炎链球菌分离株中大环内酯类耐药决定因素的模式。
Antimicrob Agents Chemother. 1999 Oct;43(10):2510-2. doi: 10.1128/AAC.43.10.2510.